Haptoglobin-related protein (Hpr) epitopes in breast cancer as a predictor of recurrence of the disease

N Engl J Med. 1989 Sep 7;321(10):636-41. doi: 10.1056/NEJM198909073211003.

Abstract

The early discrimination of clinically aggressive breast cancer from indolent disease would be clinically useful. Some human breast cancers express haptoglobin-related protein (Hpr), the HPR gene product, or a substance that shares epitopes with it. We retrospectively examined the association between the expression of Hpr and the recurrence of cancer in 70 patients with early breast cancer (Stage I or II) treated by mastectomy from 1977 through 1985, using immunohistochemical analysis of routinely processed paraffin-embedded tissue and evaluating it without knowledge of the patients' status. The expression of Hpr epitopes was associated with earlier recurrence according to life-table analysis (P less than 0.0002). Progesterone-receptor status (determined in 64 patients), tumor size, clinical stage, axillary-lymphnode status, mitotic index, and tumor necrosis also predicted recurrence, but multivariate analysis showed that Hpr-epitope expression was an independent prognostic factor. Since both Hpr status and progesterone-receptor status were independent predictors of recurrence, they could be combined to stratify the cases further: breast cancer was found to have recurred in 11 of 12 patients (92 percent) who were positive for Hpr and negative for progesterone receptors, in 5 of 11 (45 percent) who were positive for Hpr and positive for progesterone receptors, and in 9 of 41 (22 percent) who were negative for Hpr, in whom progesterone-receptor status had little effect. We conclude that Hpr-epitope expression is a clinically important predictor of the recurrence of cancer in patients with early breast cancer, especially in combination with progesterone-receptor status.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Analysis of Variance
  • Antigens, Neoplasm / analysis*
  • Biomarkers, Tumor / analysis*
  • Blood Proteins / analysis*
  • Breast Neoplasms / diagnosis*
  • Breast Neoplasms / surgery
  • Epitopes / analysis*
  • Female
  • Haptoglobins*
  • Humans
  • Mastectomy
  • Middle Aged
  • Neoplasm Recurrence, Local
  • Prognosis
  • Receptors, Progesterone / analysis
  • Retrospective Studies

Substances

  • Antigens, Neoplasm
  • Biomarkers, Tumor
  • Blood Proteins
  • Epitopes
  • HPR protein, human
  • Haptoglobins
  • Receptors, Progesterone